Genetron Holdings (Genetron Holdings) Days Inventory : 56.09 (As of Jun. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Genetron Holdings Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Genetron Holdings's Average Total Inventories for the three months ended in Jun. 2022 was $7.50 Mil. Genetron Holdings's Cost of Goods Sold for the three months ended in Jun. 2022 was $12.20 Mil. Hence, Genetron Holdings's Days Inventory for the three months ended in Jun. 2022 was 56.09.

The historical rank and industry rank for Genetron Holdings's Days Inventory or its related term are showing as below:

GTH's Days Inventory is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 65.03
* Ranked among companies with meaningful Days Inventory only.

Genetron Holdings's Days Inventory declined from Jun. 2021 (58.10) to Jun. 2022 (56.09).

Inventory Turnover measures how fast the company turns over its inventory within a year. Genetron Holdings's Inventory Turnover for the three months ended in Jun. 2022 was 1.63.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Genetron Holdings's Inventory-to-Revenue for the three months ended in Jun. 2022 was 0.36.

Genetron Holdings Days Inventory Historical Data

The historical data trend for Genetron Holdings's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetron Holdings Days Inventory Chart

Genetron Holdings Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Inventory

Get a 7-Day Free Trial

48.16

40.83

46.29

56.38

40.23

Genetron Holdings Quarterly Data
	Dec17	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22
Days Inventory	Get a 7-Day Free Trial													72.14	55.42	73.28	56.09	-

Competitive Comparison of Genetron Holdings's Days Inventory

For the Diagnostics & Research subindustry, Genetron Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genetron Holdings's Days Inventory Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetron Holdings's Days Inventory distribution charts can be found below:

* The bar in red indicates where Genetron Holdings's Days Inventory falls into.

Genetron Holdings Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Genetron Holdings's Days Inventory for the fiscal year that ended in Dec. 2022 is calculated as

	Days Inventory (A: Dec. 2022 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2021 )	+	Total Inventories (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (5.59	+	6.086)	/	2 )	/	52.968	*	365
=	5.838					/	52.968	*	365
=	40.23

Genetron Holdings's Days Inventory for the quarter that ended in Jun. 2022 is calculated as:

	Days Inventory (Q: Jun. 2022 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Mar. 2022 )	+	Total Inventories (Q: Jun. 2022 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2022 )	*	Days in Period
=	( (6.776	+	8.218)	/	2 )	/	12.196	*	365 / 4
=	7.497					/	12.196	*	365 / 4
=	56.09

Genetron Holdings (NAS:GTH) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Genetron Holdings's Inventory Turnover for the three months ended in Jun. 2022 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	12.196	/	7.497
	=	1.63

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Genetron Holdings's Inventory to Revenue for the three months ended in Jun. 2022 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	7.497	/	20.574
	=	0.36

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Genetron Holdings Days Inventory Related Terms

Thank you for viewing the detailed overview of Genetron Holdings's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetron Holdings (Genetron Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetron Holdings Ltd (NAS:GTH) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8 Life Science Parkway, 1-2nd Floor, Building 11, Zone 1, Changping District, Beijing, CHN, 102206

Website

https://www.genetronhealth.com

Genetron Holdings Ltd is an oncology company in China. It is specialized in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The company's operating segment includes Diagnosis and monitoring - provision for LDT services; Diagnosis and monitoring - sale of IVD products and Development services. It generates maximum revenue from the Diagnosis and monitoring - provision for LDT services segment.